Who
Daniel J. Luckshire
Executive VP & CFO
Company insider
Files Form 4 as: Executive VP & CFO, SIGA Technologies.
In numbers
- Trades disclosed
- 78
- Buys
- 1
- Sells
- 1
- Bought
- $22K
- Sold
- $12K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Feb 2011
- Last trade
- 13 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code M | —11,503 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code F | $32K6,074 at $5.26 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —11,503 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —11,503 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —55,228 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —55,228 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code M | —11,503 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code F | $32K6,074 at $5.26 | filing |
| 1 Jul 2025filed 2 Jul 2025 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —24,193 at $0.00 | filing |
| 1 Jul 2025filed 2 Jul 2025 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code M | —24,193 at $0.00 | filing |
| 1 Jul 2025filed 2 Jul 2025 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code F | $80K12,346 at $6.49 | filing |
| 13 Mar 2025filed 14 Mar 2025 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —34,511 at $0.00 | filing |
| 1 Jul 2024filed 3 Jul 2024 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —24,194 at $0.00 | filing |
| 1 Jul 2024filed 3 Jul 2024 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code M | —24,194 at $0.00 | filing |
| 1 Jul 2024filed 3 Jul 2024 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code F | $93K12,347 at $7.55 | filing |
| 11 May 2023filed 12 May 2023 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —48,387 at $0.00 | filing |
| 31 Jul 2021filed 3 Aug 2021 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code M | —26,667 at $0.00 | filing |
| 31 Jul 2021filed 3 Aug 2021 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code F | $89K13,902 at $6.37 | filing |
| 31 Jul 2021filed 3 Aug 2021 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —26,667 at $0.00 | filing |
| 31 Jul 2020filed 4 Aug 2020 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —26,667 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.